baber/WOPTO huggingface dataset:
Patent DK-2977385-T3 (DK)
Inventor: BLANCHE FRANCIS
IPC: G01N33/68
Filed: 2010-05-11
Granted: 2018-04-16
Abstract: The present application relates to humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide, and to the use of said antibodies in the field of Alzheimer's disease.
Patent DK-0439812-T3 (DK)
Inventor: WARNY HENRI
IPC: B65G67/02
Filed: 1990-12-21
Granted: 1993-10-11
Abstract: The invention relates to a loading platform (2) for station waggons containing a platform (4) which can be inserted into the loading space (3) of the vehicle (1) and withdrawn from the loading space (3), with which platform wheel holders (7) are swivellably connected, said wheel holders supporting the platform (4) on the ground in the swivelled-out state and lying close below the platform (4) approximately parallel thereto in the swivelled-in state. At the same time, locking devices which can be released by an actuation element (24, 41) are provided in order to secure the wheel holders (7) in the swivelled-out state and at the required length. By means of a loading platform (2) of this kind, it is possible even for a single operator to load and unload a vehicle (1) with heavy and/or bulky objects without difficulty and in a very short time.
Patent DK-0483259-T3 (DK)
Inventor: ABRAHAM FRANCIS
IPC: H01M8/12
Filed: 1990-07-18
Granted: 1994-01-31
Abstract: PCT No. PCT/FR90/00543 Sec. 371 Date Mar. 16, 1992 Sec. 102(e) Date Mar. 16, 1992 PCT Filed Jul. 18, 1990 PCT Pub. No. WO91/01274 PCT Pub. Date Feb. 7, 1991.The compositions are derived from Bi4V2O11 and are characterized by the fact that at least one of the elements present is substituted, the substituting element(s) being such that the structural nature of the gamma phase of Bi4V2O11 is maintained, as well as the equilibrium of the loads.
Patent DK-0438563-T3 (DK)
Inventor: COATES DAVID
IPC: C07C255/50
Filed: 1990-08-13
Granted: 1995-02-13
Abstract: Novel phenylcyclohexanes of the formula I in which n is 0 to 7, Q<SUP>1 </SUP>and Q<SUP>2 </SUP>are H, or one of these radicals is alternatively CH<SUB>3</SUB>, r is 0, 1, 2, 3, 4 or 5, A is trans-1,4-cyclohexylene, 1,4-phenylene, 3-fluoro-1,4-phenylene or a single bond, X is F, Cl, -CF<SUB>3</SUB>, -CN, -OCF<SUB>3 </SUB>or -OCHF<SUB>2</SUB>, and Y and Z are each, independently of one another, H or F, with the proviso that, in the case where A is a single bond, Q<SUP>1</SUP>=Q<SUP>2</SUP>=H and simultaneously X=CN, Y and/or Z are F.
Patent DK-0491803-T3 (DK)
Inventor: MAGRUDER JUDY A
IPC: A61K9/00
Filed: 1990-09-10
Granted: 1994-11-21
Abstract: An implantable dispenser is enclosed comprising a wall surrounding a compartment containing a first composition comprising a beneficial agent, an oil, a cosolvent and a polymer gellant, a second expandable composition, a third boundary maintaining composition between the first and second composition, and an exit port.
Patent DK-0457035-T3 (DK)
Inventor: BERGEMANN KLAUS DR DIPL-CHEM
IPC: C12N1/08
Filed: 1991-04-13
Granted: 1995-10-30
Abstract: A method for inactivating the biological activity of DNA, especially recombinant DNA, characterised in that the DNA is heated in the presence of an acid apart from percarboxylic acid at a concentration of at least 0.2 mM and a pH not exceeding 4, preferably 3, to a temperature of 60 to 100 DEG C.
Patent DK-0487817-T3 (DK)
Inventor: SONCINI GINO
IPC: B29C45/76
Filed: 1991-06-03
Granted: 1997-02-24
Abstract: A press (1) for injection molding plastics materials comprises machine operational members (3) to be operated by an electric control apparatus (4) to carry out the molding cycle steps in conformity with respective adjustable parameters, a power sensor (6) associated with an electric power supply line (5) to said apparatus (4) for continuously taking a measurement of the power draw by said machine operational members (3), a computer (10) being continuously supplied said power measurement to output a measurement of the power being consumed, and a display (13) being supplied said energy measurement to display it during the machine cycle such that said parameters can be adjusted to suitable values to minimize energy consumption during the cycle. <IMAGE>
Patent DK-0476449-T3 (DK)
Inventor: DUERLOO PAUL-RENE
IPC: C10L3/10
Filed: 1991-09-06
Granted: 1996-08-26
Abstract: A process is described for drying natural gas and for recycling of the water solvent used for this, in which process the natural gas is heated as required and is passed through a contacting device and in which the water solvent is recycled in a distillation device; an apparatus is also described for drying natural gas and for the recycling of the water solvent used for this, comprising a contacting device for natural gas and water solvent and a distillation device provided with a boiling chamber and distillation column, and comprising heating devices, heat exchangers and piping. The aim of the invention is to provide a simple method for drying the natural gas with less expenditure in terms of apparatus and with reduced energy consumption. The invention comprises coupling the process for drying natural gas with the process for recycling the water solvent, the water solvent being used as heat carrier for heating the natural gas, and also comprises the apparatus for heat producers and heat consumers allowing a separate constructional form.
Patent DK-0485953-T3 (DK)
Inventor: THOEN JOHAN A
IPC: C08G101/00
Filed: 1991-11-12
Granted: 1997-06-16
Abstract: This invention relates to an isocyanate-terminated prepolymer prepared from a polyisocyanate comprising 4,4'-methylene diphenyldiisocyanate and polyoxyalkylene polyol wherein the polyol has an average functionality of from 2 to 4, a hydroxyl equivalent weight of from 2200 to 3500 and contains oxyethylene residues in an amount of from 40 to 68 percent by weight; and the use thereof in a process for the manufacturing of flexible polyurethane foam.
Patent DK-0521909-T3 (DK)
Inventor: SIMONS MALCOLM J
IPC: C12N5/073
Filed: 1991-03-27
Granted: 2000-10-30
Abstract: PCT No. PCT/AU91/00115 Sec. 371 Date Nov. 2, 1992 Sec. 102(e) Date Nov. 2, 1992 PCT Filed Mar. 27, 1991 PCT Pub. No. WO91/14768 PCT Pub. Date Oct. 3, 1991.The present invention provides a method for selectively recovering fetal cells from a maternal blood sample. The method is performed on a blood sample from a pregnant woman having different first and second cell surface antigens expressed by a first allele of a polymorphic genetic locus and a second allele of a polymorphic genetic locus. The method separates maternal and fetal cells based on differential reactivities of the cells to antibodies specific for polymorphic cell surface antigens, particularly the HLA antigens. In particular, the fetal and maternal cells are separated based on the non-reactivity of the fetal cells to an antibody specific for a cell surface antigen encoded by a non-transmitted maternal allele. The method can be performed using solid phase-affixed antibody and recovering non-bound cells or using fluorescent labeled antibody and recovering unlabeled cells by fluorescence-activated cell sorting. In a preferred embodiment, the cells are also contacted with a second antibody specific for the second cell surface antigen. Fetal cells are separated based on their reaction with, at most, one of the antibodies.
Patent DK-0576426-T3 (DK)
Inventor: SINGH MOHAN BIR
IPC: C07K16/00
Filed: 1991-08-16
Granted: 1997-12-15
Abstract: The present invention provides a nucleic acid sequences coding for the ryegrass pollen allergens Lol pIa and Lol pIb, purified Lol pIa and Lol pIb protein and fragments thereof, methods of producing recombinant Lol pIa and Lol pIb or at least one fragment thereof or derivative or homologue thereof, and methods of using the nucleic acid sequences, proteins and peptides of the invention.
Patent DK-0495741-T3 (DK)
Inventor: ILIE FRANCOIS
IPC: G06Q20/06
Filed: 1992-01-16
Granted: 1996-04-22
Abstract: The present invention relates to a system for accounting for time with optimised management. It applies in particular to accounting for chargeable or regulated parking durations. 
<??>The objective is to provide a system permitting secure card changing, management of fractions of parking units, and management of the cash generated by the system, for uses in one or more municipalities. 
<??>According to the invention, the system is of the type comprising a memory card (25) and a box (10) for receiving the card (25) comprising a management memory (14) and is characterised in that the storage capacity of the said management memory (14) of the box (10) is limited to a maximum predetermined number of parking units, and in that transfer means (11) provide transfer of the balance of parking units contained in the card (25) to the said management memory (14) of the box (10) when the arithmetic total of the accumulated number of units of the said balance of the card (25) and of the current contents of the said management memory (14) of the box (10) is less than or equal to the said capacity of the management memory (14). 
<IMAGE>
Patent DK-0564513-T3 (DK)
Inventor: SCOTT RODERICK JOHN
IPC: A01H5/00
Filed: 1991-12-24
Granted: 2002-10-14
Abstract: The present invention provides recombinant or isolated DNA comprising a promoter having tapetum-specific activity. The DNA encodes a promoter which naturally drives expression of (i) a gene encoding a 10.3 kDa tapetum protein in Brassica napus which gene hybridises under stringent conditions to the cDNA shown in figure 5; or (ii) a gene encoding a tapetum protein from Brassicaceae which gene hybridises under stringent conditions to the gene shown in figure 4, the gene shown in figure 7, the cDNA shown in figure 1 or the cDNA shown in figure 5.
Patent DK-0667918-T3 (DK)
Inventor: CHALLBERG SHARON
IPC: C12Q1/68
Filed: 1992-11-12
Granted: 2000-06-05
Abstract: A non-radioactive hybridization assay and kit for the detection of genetic defects, microbial infections or viral infections, such as human papillomavirus. A test sample is treated with a base and incubated with nucleic acid probes, diluted in a neutralizing buffer, specific for target nucleic acids. The hybrids are captured onto a solid phase coated with an anti-hybrid antibody, unhybridized probe is eliminated, and the bound hybrid detected.
Patent DK-0560482-T3 (DK)
Inventor: CAIN PAUL ALFRED
IPC: A01N43/80
Filed: 1993-02-04
Granted: 1998-03-16
Abstract: 4-Benzoyl isoxazole derivatives of general formula (I): <CHEM>     wherein     R represents a hydrogen atom or a group -CO2R<5>; R<1> represents methyl, isopropyl, cyclopropyl or 1-methylcyclopropyl;     R<2> represents -S(O)nR<5><1>; R<3> represents a chlorine, bromine or fluorine atom, a straight- or branched- chain alkyl, alkoxy, haloalkyl or haloalkoxy group, an alkenyl group or a methyl or ethyl ester group; R<4> represents a chlorine, bromine or fluorine atom; an alkyl, alkoxy haloalkyl, haloalkoxy, -S(O)pR<5><3> or cyano group;     R<5> represents an alkyl or haloalkyl group;     R<5><1> and R<5><3> independently represent an alkyl group, and     n and p independently represent zero, one or two, and their use as herbicides is described.
Patent DK-0646012-T3 (DK)
Inventor: SHAH MAMTA
IPC: A61P11/00
Filed: 1993-03-22
Granted: 2003-03-03
Abstract: A healing composition containing at least one non-fibrotic growth factor in combination with a pharmaceutically acceptable carrier is disclosed. A method of preparation of the composition and method of treating a host, suffering from a wound or fibrotic condition, disease, disorder with the composition is also disclosed.
Patent DK-0637273-T3 (DK)
Inventor: MORELLO FREDERICK
IPC: E04B1/30
Filed: 1993-04-21
Granted: 2001-12-27
Abstract: A metal building is formed of adjacent preformed panels of generally U-shape with crimpable edges, the edges of adjacent panels being crimped together to form the building, the building having straight side walls and a continuous arched curved roof in which the side walls are reinforced by similar shaped straight panels positioned against the side walls to form cavities, which cavities may be filled with reinforcing material, electrical conduits and the like.
Patent DK-0647649-T3 (DK)
Inventor: ISOMURA YASUO
IPC: A61K31/675
Filed: 1993-06-18
Granted: 1999-07-26
Abstract: Crystal D or E of 1-hydroxy-2-(imidazo[1,2-a]-pyridin-3-yl)ethane-1,1-bis(phosphonic acid) monohydrate having specified lattice spacing and relative intensity in the powder X-ray diffraction spectrum obtained by using Cu-K alpha  radiation and a dehydration peak temperature of 135-149 DEG C or 160-170  DEG C according to TG-DSC thermogravimetric analysis; and a solid pharmaceutical preparation containing the same. The crystals are useful for producing a stable solid preparation of the above compound which has an excellent drug efficacy for diseases wherein increased bone resorption participates, such as osteoporosis.
Patent DK-0665720-T3 (DK)
Inventor: BURKES ALICE LYLES
IPC: A23L1/304
Filed: 1993-10-18
Granted: 1996-11-11
Abstract: This invention relates to storage stable beverage premix concentrates for preparing syrups, beverages and food compositions which are nutritionally supplemented with significant levels of calcium and to a method for preparing these concentrates. Further, this application relates to beverage flavor base compositions for preparing said beverage premix concentrates and to a method for preparing the beverage flavor base compositions. The beverage concentrates have a greater than 10 fold concentration and comprise: (a) from about 1.2% to about 7%, by weight, solubilized calcium; (b) from about 4.8% to about 47%, by weight, of an edible acid component comprising a mixture of citric acid and malic acid wherein the ratio of citric and malic equivalents to calcium equivalents is from about 1.5:1 to about 2:1 and the ratio of citric acid to malic acid equivalents is from about 3:97 to about 93:7; (c) from about 0% to about 4%, by weight, of an acidic anion component selected from the group consisting of chloride anion, nitrate anion, sulfate ion and mixtures thereof; (d) an effective amount of a flavor component; and (e) from about 5% to about 70% sugar, on a dry weight basis; (f) from about 8% to about 40%, by weight, water; wherein the weight ratio of said acid component to said solubilized calcium is from about 4 to about 7 and said beverage concentrate has a pH of less than or equal to about 4.5, preferably less than or equal to about 3.5. These beverage concentrates are stable at temperatures of greater than about 85 DEG  F. (29 DEG  C.), preferably 90 DEG  F. (32 DEG  C.), for at least about 4 hours, preferably at least about 3 days.
Patent DK-0610655-T3 (DK)
Inventor: BELLMANN GUENTHER DR
IPC: A61P25/00
Filed: 1994-01-07
Granted: 1996-07-08
Abstract: Sterile medicament for topical admin. comprises dexpanthenol (I), polyacrylate carrier (in partially neutralised form with a mol. wt. of 3,000,000-5,000,000), and opt. preservatives and/or chelating agents.
Patent DK-0679152-T3 (DK)
Inventor: FORD LARRY C
IPC: C07C59/185
Filed: 1993-10-14
Granted: 1998-02-23
Abstract: Compounds having the formula (i), (ii) and (iii),   <IMAGE> (i) <IMAGE> (ii)  <IMAGE> (iii)  where R is H, alkyl of 1 to 6 carbons, or CO-R2 where R2 is alkyl of 1 to 6 carbons; R1 is H, CH3, or (CH2)m-CH3; n is an integer having the values of 2 to 10, m is an integer having the values of 1 to 6, have anti-androgen activity on secondary androgen receptor sites. The compounds are useful for treating mammals, including humans afflicted with acne, male pattern baldness, adhesions and keloids. The compounds are also effective for treating other diseases or conditions which are related to androgen receptors, such as undesirable formation of breast capsules in females after breast augmentation surgery, osteoarthritis and symptoms of Alzheimer's disease. The compounds also have inhibitory effect on the metabolism of certain microorganisms and fungi of the kind, the metabolism of which is normally known to be controllable by anti-androgen compounds.
Patent DK-0696300-T3 (DK)
Inventor: CHUM PAK WING STEVE
IPC: C08L23/08
Filed: 1994-04-19
Granted: 1999-08-23
Abstract: The disclosed ethylene polymer compositions have et least one homogeneously branched substantially linear ethylene/ alpha -olefin interpolymer and at least one heterogeneously branched ethylene polymer. The homogeneously branched linear or substantially linear ethylene/ alpha -olefin interpolymer has a density from about 0.88 to about 0.935 g/cm<3> and a slope of strain hardening coefficient greater than or equal to about 1.3. Films made from such formulated compositions have surprisingly good impact and tensile properties, and have an especially good combination of modulus and toughness.
Patent DK-0736106-T3 (DK)
Inventor: SEUBERT PETER A
IPC: G01N33/68
Filed: 1994-10-17
Granted: 2004-02-16
Abstract: Processing of  beta -amyloid precursor protein ( beta APP) is monitored by detecting the secretion of a soluble amino-terminal fragment or  beta APP (ATF- beta APP) resulting from cleavage of  beta APP at the amino-terminus of  beta -amyloid peptide. Secretion of ATF- beta APP in animal models may be monitored to identify inhibitors of  beta -amyloid production. The ATF- beta APP may be detected using antibodies and other specific binding substances which recognize a carboxy terminal residue on the fragment. Animals expressing the Swedish mutation of  beta APP are described which produce abundant amounts of ATF- beta APP.
Patent DK-0761823-T3 (DK)
Inventor: SCHEEN HANS J
IPC: C14C9/00
Filed: 1995-11-03
Granted: 2002-10-07
Abstract: The production of household-machine washable and dryable, waterproof, nonflammable, and extremely colorfast leathers from wet blue hides by a process which has the advantage that significantly reduced volumes of toxic wastes are generated. The wet blue hides are washed and treated to equalize the pH at the surface and in the interior of the leather and to build at least one wanted end characteristics such as suppleness into the leather. This is followed by the introduction of additional character builders into the pores of the hide and the substitution of one or more softening agents for fats originally present in the pores of the hide. Next in a typical application of the invention are dyeing and the fixing of previously introduced substances in the pores of the hide. This is followed by refloatation with a hydrophobic waterproofing agent and buffering for pH equalization and increase of the pH. The hides are next treated to impart a pleasing, silky feel to the leather into which the hides are being converted and a hydrophobic silicone which promotes waterproofability and washability; and this is followed by a second fixing step.
Patent DK-0952772-T3 (DK)
Inventor: EISENBACH-SCHWARTZ MICHAL
IPC: A61K35/30
Filed: 1996-09-12
Granted: 2005-07-18
Abstract: Methods and compositions for the use of allogeneic mononuclear phagocytes to promote axonal regeneration in the central nervous system of a mammal are disclosed. In one embodiment, allogeneic mononuclear phagocytes are cultured together with stimulatory tissue, such as dermis or at least one nerve segment, and are subsequently administered into the central nervous system of a mammal at or near a site of injury or disease. In an alternative embodiment, autologous monocytes, preferably stimulated autologous monocytes, are administered into the central nervous system of a mammal at or near a site of injury or disease. Methods for identifying stimulatory tissue and cells and methods and compositions for cryopreserved allogeneic mononuclear phagocytes are also disclosed.
Patent DK-0927861-T3 (DK)
Inventor: KIMBORN GUNNAR
IPC: F24F5/00
Filed: 1997-10-31
Granted: 2000-03-27
Abstract: A cold storage unit comprises an ice store (1) with an insulated water filled container (2) which holds heat exchanger tubes (6). A medium is circulated in a primary circuit to charge the ice store, turning water in the container into ice. A secondary circuit (12) comprises primary heat exchanger tubes and a secondary heat exchanger. The working medium can be cooled in the secondary heat exchanger and is fed back through a return pipe.
Patent DK-0942729-T3 (DK)
Inventor: BAKER RAYMOND
IPC: A61K31/445
Filed: 1997-11-25
Granted: 2005-01-10
Abstract: The present invention provides the use of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of stress disorders without concomitant therapy with other anti-stress agents, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising it.
Patent DK-0933201-T3 (DK)
Inventor: FLAMM HEINZ
IPC: B65H23/188
Filed: 1998-02-02
Granted: 2004-02-09
Abstract: During operation the drive rotates at a certain speed v and produces a drive torque. The speed v is lowered or raised in dependence on the load torque according to a load characteristic line so that the drive simultaneously sets the target speed and drive moment or web tension. A guide ideal value such as a speed or position ideal value is compensated according to the load characteristic line. The dependence between the change in the load moment and the lowering or raising of the speed can be linear or non-linear.
Patent DK-0876808-T3 (DK)
Inventor: KLAIBER CHRISTIAN
IPC: A61F5/00
Filed: 1998-05-05
Granted: 2004-01-26
Abstract: The adjustable gastric strap (1) is designed to be implanted around the stomach of a patient. It has a variable volume cavity (2) filled with a liquid a system adjusts the volume of liquid in the cavity, which includes a control box (9), connected to the cavity (2) by a pipe (7), which is designed to be implanted in the patient's body. The device also includes a reservoir (11) designed to be implanted in the patient's body and to be connected to the control box (9), or incorporated in it. The control box (9) has an electrical energy source (37), an electronic control unit (28) and an electrically driven pump (22,44) controlled by the unit (28), so as to transfer liquid in a closed circuit between the reservoir (11) and the cavity (2) of the gastric strap (2).
Patent DK-0870768-T3 (DK)
Inventor: NAGEL ARTHUR ADAM
IPC: A61P25/18
Filed: 1998-04-02
Granted: 2002-07-01
Abstract: Compounds of formula I are useful in treatment of conditions associated with depletion of nicotine receptors in mammals. <CHEM>  wherein X is:     a) -CH2NR<1>R<2>,   b) <CHEM>  or;   c) <CHEM>  and R,R<1> and R<2> are independently selected from hydrogen and C1-C6 alkyl;   R<3> is selected from hydrogen, halogen and C1-C6 alkyl;   l is an integer from 0-4;m is an integer from 0-4; and n is an integer from 0-2; or a pharmaceutically acceptable salt thereof.
Patent DK-0873993-T3 (DK)
Inventor: GUILLAUMET GERALD
IPC: A61P25/28
Filed: 1998-04-23
Granted: 2002-06-10
Abstract: Benzodioxin and benzoxathiin derivatives of formula (I), their enantiomers, diastereoisomers, and salts with acids and bases are new: X, Y = S, O, CHq, CHSO or SO2, such that X, Y may not both be CHq; q = 0-2; Z = O or CH2; n = 0-4; A = -NR1R2 or a group -C(=T')NR6R7; R1 = H or 1-6C alkyl; R2 = -C(=T)R3; T = O or S; R3 = R'3 or -NR4R5; R'3 = H, 1-6C alkyl, 2-6C alkenyl, 1-6C alkynyl (sic), 3-8C cycloalkyl, cycloalkyl alkyl (all optionally substituted), or aryl or aralkyl; R4 = H or 1-6C alkyl; R5 = H, 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl, cycloalkyl, cycloalkyl alkyl (all optionally substituted) or aryl or arylalkyl; T' = O or S; R6 = H or 1-6C alkyl; R7 = H, 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl, cycloalkyl or cycloalkyl alkyl (all optionally substituted) or aryl or arylalkyl; R = H, 1-6C alkyl (optionally substituted), aryl or aralkyl; Ring A = optionally substituted by one or more halo, OH, 1-6C alkyl or alkoxy, CN, NO2, NH2 or trihaloalkyl; arylalkyl = 1-6C alkyl substituted by aryl; cycloalkyl alkyl = 1-6C alkyl substituted by 3-8C cycloalkyl; provided that when X, Z both = CH2, R = H, and A = NR1R2, then Y is not O; and when Z = O, n is not zero, and when Z = O and n = 1, then A is not CONEt2; when Z = CH2, n = 1, A = -NR1CSNR4R5, then R2 is not aryl; and when X = Y = O, the dotted lines in ring A are single bonds, R = H or CH2OH, then A is not NR1R2a; R2a = benzoyl (optionally substituted).